Filing Details
- Accession Number:
- 0001209191-17-021759
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-20 16:46:21
- Reporting Period:
- 2017-03-17
- Filing Date:
- 2017-03-20
- Accepted Time:
- 2017-03-20 16:46:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 821995 | Juniper Pharmaceuticals Inc | JNP | Pharmaceutical Preparations (2834) | 592758596 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1239746 | A James Geraghty | C/O Juniper Pharmecuticals, Inc. 33 Arch Street, Suite 3110 Boston MA 02110 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.01 | Acquisiton | 2017-03-17 | 2,000 | $4.82 | 65,153 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.814 to $4.8234, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
Billionaire Hedge Funds
